tradingkey.logo

Penumbra Inc

PEN
298.710USD
+0.600+0.20%
終値 11/25, 16:00ET15分遅れの株価
11.69B時価総額
71.30直近12ヶ月PER

Penumbra Inc

298.710
+0.600+0.20%

詳細情報 Penumbra Inc 企業名

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Penumbra Incの企業情報

企業コードPEN
会社名Penumbra Inc
上場日Sep 18, 2015
最高経営責任者「CEO」Mr. Adam Elsesser, J.D.
従業員数4500
証券種類Ordinary Share
決算期末Sep 18
本社所在地One Penumbra Place
都市ALAMEDA
証券取引所NYSE Consolidated
United States of America
郵便番号94502
電話番号15109952486
ウェブサイトhttps://www.penumbrainc.com/
企業コードPEN
上場日Sep 18, 2015
最高経営責任者「CEO」Mr. Adam Elsesser, J.D.

Penumbra Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.96K
+4.41%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
28.34K
+10.65%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.60K
-1.33%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
53.96K
+4.41%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
28.34K
+10.65%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.60K
-1.33%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%
地域別USD
会社名
収益
比率
United States
260.82M
76.83%
International
78.64M
23.17%
事業別
地域別
事業別USD
会社名
収益
比率
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%

株主

更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
13.02%
The Vanguard Group, Inc.
9.77%
BlackRock Institutional Trust Company, N.A.
9.14%
T. Rowe Price Associates, Inc.
4.49%
State Street Investment Management (US)
2.97%
他の
60.60%
株主統計
株主統計
比率
Fidelity Management & Research Company LLC
13.02%
The Vanguard Group, Inc.
9.77%
BlackRock Institutional Trust Company, N.A.
9.14%
T. Rowe Price Associates, Inc.
4.49%
State Street Investment Management (US)
2.97%
他の
60.60%
種類
株主統計
比率
Investment Advisor
61.43%
Investment Advisor/Hedge Fund
23.61%
Hedge Fund
7.37%
Individual Investor
3.73%
Research Firm
1.96%
Pension Fund
1.65%
Sovereign Wealth Fund
1.20%
Private Equity
0.56%
Bank and Trust
0.43%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
852
37.12M
94.79%
-3.14M
2025Q2
864
37.32M
95.72%
-2.83M
2025Q1
878
36.92M
95.33%
-3.44M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Fidelity Management & Research Company LLC
5.04M
12.92%
+93.97K
+1.90%
Jun 30, 2025
The Vanguard Group, Inc.
3.85M
9.88%
+185.31K
+5.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.61M
9.25%
+78.78K
+2.23%
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.34M
3.44%
+164.55K
+13.99%
Jun 30, 2025
State Street Investment Management (US)
1.17M
3%
-26.92K
-2.25%
Jun 30, 2025
Elsesser (Adam)
1.02M
2.62%
+12.18K
+1.21%
Sep 03, 2025
Baillie Gifford & Co.
922.13K
2.36%
+233.13K
+33.84%
Jun 30, 2025
RTW Investments L.P.
863.55K
2.21%
+783.00
+0.09%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Motley Fool Small-Cap Growth ETF
3%
Congress SMid Growth ETF
2.21%
First Trust Indxx Medical Devices ETF
1.76%
ROBO Global Healthcare Technology & Innovation ETF
1.65%
Invesco S&P MidCap Quality ETF
1.62%
Simplify Health Care ETF
1.62%
SPDR S&P Health Care Equipment ETF
1.53%
Putnam Sustainable Future ETF
1.35%
iShares U.S. Medical Devices ETF
1.19%
Invesco S&P MidCap Momentum ETF
1.18%
詳細を見る
Motley Fool Small-Cap Growth ETF
比率3%
Congress SMid Growth ETF
比率2.21%
First Trust Indxx Medical Devices ETF
比率1.76%
ROBO Global Healthcare Technology & Innovation ETF
比率1.65%
Invesco S&P MidCap Quality ETF
比率1.62%
Simplify Health Care ETF
比率1.62%
SPDR S&P Health Care Equipment ETF
比率1.53%
Putnam Sustainable Future ETF
比率1.35%
iShares U.S. Medical Devices ETF
比率1.19%
Invesco S&P MidCap Momentum ETF
比率1.18%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Penumbra Incの上位5名の株主は誰ですか?

Penumbra Incの上位5名の株主は以下のとおりです。
Fidelity Management & Research Company LLCは5.04M株を保有しており、これは全体の12.92%に相当します。
The Vanguard Group, Inc.は3.85M株を保有しており、これは全体の9.88%に相当します。
BlackRock Institutional Trust Company, N.A.は3.61M株を保有しており、これは全体の9.25%に相当します。
T. Rowe Price Associates, Inc.は1.34M株を保有しており、これは全体の3.44%に相当します。
State Street Investment Management (US)は1.17M株を保有しており、これは全体の3.00%に相当します。

Penumbra Incの株主タイプ上位3種は何ですか?

Penumbra Incの株主タイプ上位3種は、
Fidelity Management & Research Company LLC
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.

Penumbra Inc(PEN)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Penumbra Incの株式を保有している機関は852社あり、保有株式の総市場価値は約37.12Mで、全体の94.79%を占めています。2025Q2と比較して、機関の持ち株は-0.93%増加しています。

Penumbra Incの最大の収益源は何ですか?

FY2025Q2において、Thrombectomy部門がPenumbra Incにとって最大の収益を生み出しており、その金額は230.26Mで、全収益の67.83%を占めています。
KeyAI